JP2012531896A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531896A5
JP2012531896A5 JP2012517837A JP2012517837A JP2012531896A5 JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5 JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5
Authority
JP
Japan
Prior art keywords
human
cells
mammal
functional
human mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012517837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531896A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/040260 external-priority patent/WO2011002727A1/en
Publication of JP2012531896A publication Critical patent/JP2012531896A/ja
Publication of JP2012531896A5 publication Critical patent/JP2012531896A5/ja
Pending legal-status Critical Current

Links

JP2012517837A 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法 Pending JP2012531896A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22143809P 2009-06-29 2009-06-29
US61/221,438 2009-06-29
PCT/US2010/040260 WO2011002727A1 (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals

Publications (2)

Publication Number Publication Date
JP2012531896A JP2012531896A (ja) 2012-12-13
JP2012531896A5 true JP2012531896A5 (cg-RX-API-DMAC7.html) 2013-08-15

Family

ID=43411395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517837A Pending JP2012531896A (ja) 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法

Country Status (6)

Country Link
US (1) US20120157667A1 (cg-RX-API-DMAC7.html)
EP (1) EP2449094A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012531896A (cg-RX-API-DMAC7.html)
CN (1) CN102725400A (cg-RX-API-DMAC7.html)
SG (2) SG10201403703XA (cg-RX-API-DMAC7.html)
WO (1) WO2011002727A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4502152A3 (en) 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
WO2013086019A1 (en) * 2011-12-06 2013-06-13 Massachusetts Institute Of Technology Use of humanized mice to determine toxicity
CN103387955B (zh) * 2012-05-10 2015-04-29 上海南方模式生物科技发展有限公司 非人哺乳动物b淋巴细胞缺陷动物模型的制备方法及其用途
WO2014039733A1 (en) * 2012-09-05 2014-03-13 University Of Southern California Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins
KR102241962B1 (ko) * 2012-09-07 2021-04-20 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
DK4389764T3 (da) * 2012-11-05 2026-04-13 Regeneron Pharma Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
WO2014121840A1 (en) * 2013-02-07 2014-08-14 Medizinische Hochschule Hannover Induced dendritic cells and uses thereof
WO2014196929A1 (en) * 2013-06-05 2014-12-11 Agency For Science, Technology And Research A humanized mouse model for study of bona fide hepatitis virus infection and use thereof
NO2785538T3 (cg-RX-API-DMAC7.html) * 2014-05-07 2018-08-04
EP3482629B1 (en) * 2014-05-19 2020-11-25 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
ES2950399T3 (es) 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトil−15分泌免疫不全マウス
EP3383173B1 (en) * 2015-11-30 2020-11-25 H. Hoffnabb-La Roche Ag Generation of human macrophages in immunodeficient mice
US20200315147A1 (en) * 2017-11-17 2020-10-08 University Of Tsukuba Non-human animal and method for producing same
CN111304248B (zh) 2018-12-25 2021-08-24 百奥赛图江苏基因生物技术有限公司 人源化细胞因子il15基因改造非人动物的构建方法及应用
CN111172190B (zh) * 2018-12-25 2021-07-30 百奥赛图江苏基因生物技术有限公司 人源化细胞因子csf2基因改造非人动物的构建方法及应用
WO2020157997A1 (ja) * 2019-01-28 2020-08-06 公益財団法人実験動物中央研究所 ヒトil-34を有する非ヒト動物及びその使用
CN113677199A (zh) * 2019-02-13 2021-11-19 杰克逊实验室 支持先天免疫功能的转基因小鼠模型
US20220192166A1 (en) * 2019-03-28 2022-06-23 Central Institute For Experimental Animals Immunodeficient rodent
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
US20230340524A1 (en) * 2020-07-08 2023-10-26 The Jackson Laboratory Transgenic mouse models supporting human innate immune function
CN112042597B (zh) * 2020-07-22 2022-04-29 南京普恩瑞生物科技有限公司 一种双人源化肿瘤异种移植模型的构建方法
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用
CN117070524A (zh) * 2022-08-15 2023-11-17 江苏集萃药康生物科技股份有限公司 一种白介素人源化的非人动物的制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853201T2 (de) * 1987-12-23 1995-09-14 Univ Leland Stanford Junior Schimäre immunkompromittierende Säugetiere und ihre Verwendung.
US5639939A (en) * 1987-12-23 1997-06-17 The Board Of Trustees For The Leland Stanford Junior University Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
JPH09506626A (ja) * 1993-12-17 1997-06-30 システミクス・インコーポレイテッド 非自己造血細胞移植片の生存延長のためのマクロファージ枯渇剤の使用および動物モデル検定系
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
US20070021364A1 (en) * 1995-12-13 2007-01-25 Hans Herweijer Methods for genetic immunization
WO1999061589A2 (en) * 1998-05-28 1999-12-02 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU4323599A (en) * 1998-05-29 1999-12-13 Instituto Superiore Di Sanita Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
JP2006501177A (ja) * 2002-06-24 2006-01-12 ジェンザイム・コーポレイション 遺伝子治療薬を送達する方法
GB0406728D0 (en) * 2004-03-25 2004-04-28 Hydrodynamic Gene Delivery Ltd Gene therapy
US8252587B2 (en) * 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
AU2007238660C1 (en) * 2006-04-14 2013-11-07 Astellas Institute For Regenerative Medicine Hemangio-colony forming cells
CA2680613A1 (en) * 2007-03-13 2008-09-18 National Jewish Medical And Research Center Methods for generation of antibodies
CA2636876A1 (en) * 2008-02-25 2009-08-25 Gestion Univalor Inc. Methods and kits for expanding hematopoietic stem cells
WO2010115115A1 (en) * 2009-04-03 2010-10-07 Inserm ( Institut National De La Sante Et De La Recherche) Dendritic cell-boosted humanized immune system mice
SG10201403707QA (en) * 2009-06-29 2014-10-30 Ilya B Leskov Non-human mammal model of human hematopoietic cancer
EP4502152A3 (en) * 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment

Similar Documents

Publication Publication Date Title
Martinov et al. Building the next generation of humanized hemato-lymphoid system mice
De La Rochere et al. Humanized mice for the study of immuno-oncology
Wege Humanized mouse models for the preclinical assessment of cancer immunotherapy
AU2018202976B2 (en) Polyclonal gamma delta t cells for immunotherapy
Majc et al. Immunotherapy of glioblastoma: current strategies and challenges in tumor model development
Calmeiro et al. Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells
Cho et al. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells
CN102725400A (zh) 制造人源化的非人类哺乳动物的方法
Hara et al. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region
ES2700852T3 (es) Ratones modificados genéticamente e injerto
Salguero et al. Dendritic cell–mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation
IL299249B1 (en) Genetically modified immune cells that include adapted shrna-microRNA (shrnamir)
Bemark et al. Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation–revelation of B cell developmental pathways and lineage phenotypes
JP2015534819A5 (cg-RX-API-DMAC7.html)
EP4251177A2 (en) Antigen specific t cells and methods of making and using same
EP2495312A1 (en) Method for producing antigen-specific b cell population
Ren et al. Translational models in glioma immunotherapy research
Eguren-Santamaria et al. Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic
Ghasemi et al. Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models
Akkina Humanized mice for studying human immune responses and generating human monoclonal antibodies
Läderach et al. MHC class II‐deficient mice allow functional human CD4+ T‐cell development
Xun et al. Induced pluripotent stem cell-based cancer immunotherapy: strategies and perspectives
DOYLE et al. The CD4+ T‐cell response to protein immunization is independent of accompanying IFN‐γ‐producing CD8+ T cells
C Harman et al. Antibody discovery from immune competent and immune transplanted mice
Patel et al. Diverse T‐cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta‐like‐1‐modified mouse stromal cells